Related Experiment Video
Updated: Apr 27, 2026

Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction
Published on: June 29, 2013
Gender-specific relationship between prenatal exposure to phthalates and intrauterine growth restriction
Yan Zhao1, Li Chen1, Lu-Xi Li1
1Department of Environmental Health, School of Public Health, Fudan University, Shanghai, China.
Insights
Prenatal phthalate exposure is linked to a higher risk of intrauterine growth retardation (IUGR), especially in male newborns. Higher phthalate metabolite levels in mothers correlated with reduced fetal growth.
Area of Science:
- Environmental Health
- Reproductive Toxicology
- Perinatal Medicine
Background:
- No prior studies have investigated the link between prenatal phthalate exposure and intrauterine growth retardation (IUGR).
- This research addresses the knowledge gap concerning phthalate exposure during pregnancy and its impact on fetal development.
Purpose of the Study:
- To determine the association between prenatal phthalate exposure and the risk of developing IUGR.
- To explore potential sex-specific differences in susceptibility to phthalate exposure regarding fetal growth.
Main Methods:
- A case-control study involving 126 mother-newborn pairs (42 IUGR cases, 84 controls).
- Maternal urine samples collected in the third trimester analyzed for five phthalate metabolites.
- Phthalate metabolite concentrations were quantified using established laboratory techniques.
Main Results:
- Elevated levels of monomethyl phthalate (MMP), mono(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), mono(2-ethyl-5-oxohexyl) phthalate (MEOHP), and SumDEHP were found in IUGR cases.
- Higher MEHHP and MEOHP concentrations were inversely associated with fetal growth indicators (birth weight, Quetelet's index) in the overall cohort.
- A significant exposure-response relationship was observed between MEHHP/SumDEHP and IUGR; male infants showed greater sensitivity to phthalate exposure than females.
Conclusions:
- Prenatal phthalate exposure is associated with an increased risk of intrauterine growth retardation.
- Male newborns appear more vulnerable to the adverse effects of phthalate exposure on fetal growth compared to females.
- Findings highlight the importance of monitoring and reducing phthalate exposure during pregnancy to improve perinatal outcomes.
Background:
No study has examined the association between prenatal phthalate exposure and intrauterine growth retardation (IUGR). This study aimed to investigate whether prenatal exposure to phthalates was associated with increased risk of IUGR.
Methods:
A total of 126 mother-newborn pairs, including 42 IUGR cases and 84 control newborns and their mothers, were enrolled in this case-control study. Spot urine samples were collected during the third trimester of pregnancy, and 5 phthalate metabolites (mono-n-butyl phthalate (MBP), monomethyl phthalate (MMP), mono-2-ethylhexyl phthalate (MEHP), mono(2-ethyl-5-oxohexyl) phthalate (MEOHP), and mono(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP)) were measured.
Results:
Concentrations of MMP, MEHHP, MEOHP, and SumDEHP (MEHP, MEHHP, and MEOHP) were significantly higher in IUGR cases than in normal controls. In all subjects, urinary concentrations of MEHHP and MEOHP were significantly inversely associated with fetal growth indicators (birth weight and Quetelet's index). When mothers were stratified by infant sex, MEHHP and MEOHP concentrations were still negatively associated with fetal growth indicators, while no significant association was observed in females. In addition, exposure-response relationships were observed between MEHHP/SumDEHP concentrations in maternal urine and IUGR.
Conclusion:
Prenatal exposure to phthalates was associated with increased risk of IUGR, and male newborns were more sensitive to phthalates than females.
Related Concept Videos
Teratogenicity
Nature and Nurture
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Inborn Errors of Metabolism
Pharmacokinetics in Pediatric Patients: Drug Distribution
Regression Toward the Mean

